Morgan Stanley analyst Vincent Andrews initiated Chemours with an Equal Weight rating and $57.50 price target, stating that he is constructive on Ti02 prices, but expects more gradual price upside and less frequent increases compared to the past 18 months.
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here